Cancer Cell Detection and Molecular Profiling Using Diagnostic Magnetic Resonance
暂无分享,去创建一个
[1] Hakho Lee,et al. Micro-NMR for Rapid Molecular Analysis of Human Tumor Samples , 2011, Science Translational Medicine.
[2] Hakho Lee,et al. Bioorthogonal chemistry amplifies nanoparticle binding and enhances the sensitivity of cell detection. , 2010, Nature nanotechnology.
[3] Chad A. Mirkin,et al. Drivers of biodiagnostic development , 2009, Nature.
[4] S. Digumarthy,et al. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Ralph Weissleder,et al. Fast and sensitive pretargeted labeling of cancer cells through a tetrazine/trans-cyclooctene cycloaddition. , 2009, Angewandte Chemie.
[6] Hakho Lee,et al. Rapid detection and profiling of cancer cells in fine-needle aspirates , 2009, Proceedings of the National Academy of Sciences.
[7] Hakho Lee,et al. Ultrasensitive detection of bacteria using core-shell nanoparticles and an NMR-filter system. , 2009, Angewandte Chemie.
[8] M. Somerfield,et al. American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] R. Weissleder,et al. Tetrazine-based cycloadditions: application to pretargeted live cell imaging. , 2008, Bioconjugate chemistry.
[10] Donhee Ham,et al. Chip–NMR biosensor for detection and molecular analysis of cells , 2008, Nature Medicine.
[11] Ralph Weissleder,et al. Sensitive NMR sensors detect antibodies to influenza. , 2008, Angewandte Chemie.
[12] James R Heath,et al. Nanotechnology and cancer. , 2008, Annual review of medicine.
[13] Yong Liu,et al. Integrated cell manipulation system--CMOS/microfluidic hybrid. , 2007, Lab on a chip.
[14] Lesley Seymour,et al. Erlotinib in lung cancer - molecular and clinical predictors of outcome. , 2005, The New England journal of medicine.
[15] Ralph Weissleder,et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. , 2003, The New England journal of medicine.